HCV-related extra-hepatic complications include peripheral neuropathies, with important prevalence and impact. A recent metanalysis of previous intervention trials concluded for insufficient data to support evidence-based treatments for this complication. In this longitudinal study, we assessed for the first time prevalence and outcome of neuropathy in a cohort of patients with chronic HCV, before and after direct-acting antiviral agent (DAA) treatment.

中文翻译：

---

慢性丙型肝炎使用直接作用抗病毒药物根除病毒后周围神经病变：一项前瞻性研究


HCV 相关的肝外并发症包括周围神经病变，具有重要的患病率和影响。最近对之前的干预试验进行的荟萃分析得出的结论是，数据不足以支持这种并发症的循证治疗。在这项纵向研究中，我们首次评估了一组慢性丙型肝炎患者在直接作用抗病毒药物（DAA）治疗前后神经病变的患病率和结果。